N

NGM Biopharmaceuticals Inc
F:0IK

Watchlist Manager
NGM Biopharmaceuticals Inc
F:0IK
Watchlist
Price: 1.41 EUR Market Closed
Market Cap: 117.7m EUR

Intrinsic Value

The intrinsic value of one 0IK stock under the Base Case scenario is hidden EUR. Compared to the current market price of 1.41 EUR, NGM Biopharmaceuticals Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

0IK Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
NGM Biopharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

0IK looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if 0IK is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about 0IK?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 0IK valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for NGM Biopharmaceuticals Inc.

Explain Valuation
Compare 0IK to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about 0IK?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
NGM Biopharmaceuticals Inc

Balance Sheet Decomposition
NGM Biopharmaceuticals Inc

Current Assets 237m
Cash & Short-Term Investments 34.3m
Receivables 36.9m
Other Current Assets 165.8m
Non-Current Assets 89m
PP&E 9m
Intangibles 78.1m
Other Non-Current Assets 1.9m
Current Liabilities 81.8m
Accounts Payable 66m
Accrued Liabilities 7.4m
Other Current Liabilities 8.4m
Non-Current Liabilities 25.4m
Long-Term Debt 4.5m
Other Non-Current Liabilities 20.9m
Efficiency

Free Cash Flow Analysis
NGM Biopharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
NGM Biopharmaceuticals Inc

Revenue
251m USD
Cost of Revenue
-188.8m USD
Gross Profit
62.2m USD
Operating Expenses
-47.2m USD
Operating Income
15m USD
Other Expenses
-5.5m USD
Net Income
9.5m USD
Fundamental Scores

0IK Profitability Score
Profitability Due Diligence

NGM Biopharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Low 3Y Average Operating Margin
Low 3Y Average Net Margin
hidden
Profitability
Score

NGM Biopharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

0IK Solvency Score
Solvency Due Diligence

NGM Biopharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
Negative Net Debt
Low D/E
Long-Term Solvency
hidden
Solvency
Score

NGM Biopharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

0IK Price Targets Summary
NGM Biopharmaceuticals Inc

Wall Street analysts forecast 0IK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0IK is 5.56 EUR with a low forecast of 4.33 EUR and a high forecast of 7.22 EUR.

Lowest
Price Target
4.33 EUR
207% Upside
Average
Price Target
5.56 EUR
294% Upside
Highest
Price Target
7.22 EUR
412% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

NGM Biopharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for 0IK is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one 0IK stock?

The intrinsic value of one 0IK stock under the Base Case scenario is hidden EUR.

Is 0IK stock undervalued or overvalued?

Compared to the current market price of 1.41 EUR, NGM Biopharmaceuticals Inc is hidden .

Back to Top